| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/26/2003 | CN1457779A Medicinal composition for curing trachitis |
| 11/26/2003 | CN1457778A Subprostrate sophora oral preparation, preparing method and use |
| 11/26/2003 | CN1457777A New use of indole derivatives as anti-SARS medicine |
| 11/26/2003 | CN1457776A Self emulsified soft capsule of ginkgo leaf extract and its preparing method |
| 11/26/2003 | CN1457775A Composition containing dihydro myricitrin and myricitrin |
| 11/26/2003 | CN1457774A Use of ampelopsin for preparing blood sugar reducing medicine |
| 11/26/2003 | CN1457773A Biguanide vanadium complex granular powder and/or capsule for curing diabetes and its use |
| 11/26/2003 | CN1457772A Injection for curing acute lung injury and acute respirotary distress syndrome |
| 11/26/2003 | CN1457771A 1'-acetoxyl chavicol acetate with anti-HIV activity and its derivatives |
| 11/26/2003 | CN1457766A Mucilage antiseptic medicine composition capable of being locally administratied and sustainably released and its preparing method |
| 11/26/2003 | CN1457765A Cetirizine hydrochloride gel |
| 11/26/2003 | CN1457705A Process for producing Haoyin companion |
| 11/26/2003 | CN1457688A Brain strengthening chewing tablet for child |
| 11/26/2003 | CN1457670A Slowly digestable starch product |
| 11/26/2003 | CN1128805C Polymorphic clopidogrel hydrogenesulphate form and its preparing method and pharmaceutical compositions |
| 11/26/2003 | CN1128804C Method for purifying dehydrated sugar alcohol and product |
| 11/26/2003 | CN1128801C Triazolo (4,5-D) pyrimidine compounds |
| 11/26/2003 | CN1128800C Pyrolo [2,3-d] pyrimidine compounds and its composition and use |
| 11/26/2003 | CN1128798C Pharmaceutically active tricyclic amines |
| 11/26/2003 | CN1128797C Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C- linked imidazoles |
| 11/26/2003 | CN1128795C Semi-synthetic taxane having anti-tumor activity |
| 11/26/2003 | CN1128790C 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents |
| 11/26/2003 | CN1128789C Benzocycloheptathiophene compounds |
| 11/26/2003 | CN1128788C Benzyl(idene)-lactam derivatives, their prepn. and their use as selective(ant) agonists of 5-HT 1A and/or 5-HT 1D receptors |
| 11/26/2003 | CN1128786C Manufacturing process of metoprolol |
| 11/26/2003 | CN1128635C Amber anti-inflammatory pain-stopping powder medicine |
| 11/26/2003 | CN1128633C Exterior-applied medicine for treating gynopathy |
| 11/26/2003 | CN1128631C External-use medicinal plaster for curing bone disease |
| 11/26/2003 | CN1128628C Chinese medicine for treating alopecia areata |
| 11/26/2003 | CN1128627C Plaster for treating rheumatism and its preparing method |
| 11/26/2003 | CN1128624C Process for preparing powdered medicine to treat rhinitis and nasosinusitis |
| 11/26/2003 | CN1128623C Instant effervescent particles for Ca-supplementing health-care products and its preparing process |
| 11/26/2003 | CN1128622C Medicinal composition for treating AIDS |
| 11/26/2003 | CN1128621C Use of ginsengdiol histsaponin and its composition in preparing medicine for treating hematopathy |
| 11/26/2003 | CN1128620C Use of levobupivacaine in preparing medicine for treating migraine |
| 11/26/2003 | CN1128619C Utilization of powder prepns. contg. hydroxypyridones treating leg ulcer and decubitus ulcers |
| 11/26/2003 | CN1128618C Use of histamine for elevating blood histamine |
| 11/26/2003 | CN1128617C Preparation method for medicinal composition containing triazolyl derivative |
| 11/26/2003 | CN1128616C Use of water-free lactose in producing solid mixtures containing nitroglycerine |
| 11/26/2003 | CN1128615C Pharmaceutical compositions for prevention and treatment of cancerous disease and process for their preparation |
| 11/26/2003 | CN1128614C Use of dichlorobenzyl alcohol for preparing a preparation for topical treatment of inflammation and preparation containing it |
| 11/26/2003 | CN1128613C Combination of progresterone antagonists and anti-oestrogens with partial agonistic action for use in hormone-replacement therapy for perio- and post menopansal woman |
| 11/26/2003 | CN1128612C Pharmaceutical composition with base of rhein or diacerhein with improved biological availability |
| 11/26/2003 | CN1128574C Corneal storage fluid comprised of hyaluronic acid |
| 11/25/2003 | USRE38332 Selected soluble esters of hydroxyl-containing indolocarbazoles |
| 11/25/2003 | USRE38330 Preventing and reversing advanced glycosylation endproducts |
| 11/25/2003 | US6653508 Use treating various medical conditions, including pain |
| 11/25/2003 | US6653505 Oxidation resistance |
| 11/25/2003 | US6653493 Lipoxin compounds and their use in treating cell proliferative disorders |
| 11/25/2003 | US6653481 Used as calcium channel blockers |
| 11/25/2003 | US6653479 Crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b] thiophene hydrochloride |
| 11/25/2003 | US6653476 Thienopyridine derivatives, their production and use |
| 11/25/2003 | US6653475 Coupling a compound with pyrimidone intermediate |
| 11/25/2003 | US6653471 Tricyclic heteroaromatic compounds containing pyrrole ring; central nervous system disorder treatment; side effect reduction |
| 11/25/2003 | US6653466 Active principle comprises antisense oligonucleotide consisting of a 20 to 50-nucleotide sequence against exon 19 of dystrophin pre-mRNA |
| 11/25/2003 | US6653456 Site-specific aminoglycoside derivatives and their use in immunodiagnostic assays |
| 11/25/2003 | US6653448 Wnt-7B-like polypeptides and nucleic acids encoding same |
| 11/25/2003 | US6653426 Polymer compositions for intraluminal stent |
| 11/25/2003 | US6653352 Pain reliever and method of use |
| 11/25/2003 | US6653351 Adjuvant chemotherapy for anaplastic gliomas |
| 11/25/2003 | US6653350 Methods of treating osteoarthritis with inducible nitric oxide synthase inhibitors |
| 11/25/2003 | US6653349 Synergistic combination of acetyl L-carnitine and propionyl L-carnitine |
| 11/25/2003 | US6653348 Antiinflammatory agent for humans |
| 11/25/2003 | US6653347 For therapy |
| 11/25/2003 | US6653345 A prostanoic acid derivative as c-c chemokine synthesis inhibitor and useful for the treatment of circulatory diseases, inflammation, allergic and renal diseases |
| 11/25/2003 | US6653344 Pharmaceutical preparations containing a dibenzocyclooctane lignan derivative for treatment of neurodegenerative disease |
| 11/25/2003 | US6653341 Using halichondrin B analog in combined therapy |
| 11/25/2003 | US6653339 Method of treating irritable bowel syndrome |
| 11/25/2003 | US6653338 FSH mimetics for the treatment of infertility |
| 11/25/2003 | US6653337 Active ingredient mono-L-aspartyl chlorin e6 or mono-L-glutamyl chlorin e6 or salt |
| 11/25/2003 | US6653336 Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders |
| 11/25/2003 | US6653335 Pharmaceutical composition for inhibiting the growth of viruses and cancers |
| 11/25/2003 | US6653334 Benzoxazole compound and pharmaceutical composition containing the same |
| 11/25/2003 | US6653333 Especially N-(2-ethylsulfonylamino-5-trifluoromethyl-3-pyridyl)cyclohexane; treating inflammatory bowel diseases, gastritis and peptic ulcer. |
| 11/25/2003 | US6653332 Combination therapeutic compositions and method of use |
| 11/25/2003 | US6653331 Targeted drug delivery using sulfonamide derivatives |
| 11/25/2003 | US6653330 Amide-type triazole compounds |
| 11/25/2003 | US6653329 Granulated pharmaceutical formulations and methods for making the same |
| 11/25/2003 | US6653327 Cross-regulin composition of tumeric-derived tetrahydrocurcuminoids for skin lightening and protection against UVB rays |
| 11/25/2003 | US6653326 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
| 11/25/2003 | US6653325 Dyskinesias, by administering a substituted phenylazacycloalkane and a dopamine agonist to the patient |
| 11/25/2003 | US6653322 Therapeutic combinations of RAR antagonists and RXR agonists and use thereof |
| 11/25/2003 | US6653321 Stimulating kinase activity of insulin receptor; type II diabetes; hyperglycemia |
| 11/25/2003 | US6653320 Such as 3-(6-bromo-2-methylimidazo(1,2-a)pyridin-3-yl)-1H-pyrazol-1-yl 2-methyl-5-nitrophenyl sulfone; useful as phosphatidylinositol-3-kinase (PI3K) inhibitors and antitumor agents |
| 11/25/2003 | US6653317 2-amino-4-alkylamino-6-alkoxypyrimidine 3-oxides |
| 11/25/2003 | US6653315 Substituted 5-amino-imidazolo-(4,3-e)-1,2,4-triazolo(1,5-c)-pyrimidines; central nervous system diseases; Parkinson's disease |
| 11/25/2003 | US6653313 1,4-dihydropyridine compounds as bradykinin antagonists |
| 11/25/2003 | US6653312 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 11/25/2003 | US6653310 For therapy of disease states mediated by the chemokine, Interleukin-8 (IL-8) |
| 11/25/2003 | US6653309 Binding ligands |
| 11/25/2003 | US6653308 Anticancer agents; antidiabetic agents; antiinflammatory agents |
| 11/25/2003 | US6653307 1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents |
| 11/25/2003 | US6653306 Epoxy-steroidal aldosterone antagonist and angiotensin II antagonist combination therapy |
| 11/25/2003 | US6653305 For therapy of tumoral diseases, diseases of the lungs and respiratory tract |
| 11/25/2003 | US6653304 Antiarthritic agents; skin disorders; anticarcinogenic agents |
| 11/25/2003 | US6653303 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| 11/25/2003 | US6653302 Quinoline and quinazoline compounds useful in therapy |
| 11/25/2003 | US6653301 For therapy of cancer, diabetes and Alzheimer's disease |
| 11/25/2003 | US6653300 Pyrazole compounds useful as protein kinase inhibitors |
| 11/25/2003 | US6653298 Compounds such as esterone-3-sulfamate in a dosage >/= 200 micrograms/day used as oral contraceptives, hormone replacement therapy and/or inhibition of esterone sulfatae |